Secondhand smoke in apartment buildings: renter and owner or manager perspectives.

PubWeight™: 2.31‹?› | Rank: Top 2%

🔗 View Article (PMID 17365725)

Published in Nicotine Tob Res on January 01, 2007

Authors

Martha J Hewett1, Sandra D Sandell, John Anderson, Marsha Niebuhr

Author Affiliations

1: Center for Energy and Environment, Minneapolis, MN 55401-1459, USA. mhewett@mncee.org

Associated clinical trials:

Supporting Smoke-Free Policy Compliance in Public Housing | NCT05016505

Articles citing this

Secondhand smoke transfer in multiunit housing. Nicotine Tob Res (2010) 2.27

Multiunit housing residents' experiences and attitudes toward smoke-free policies. Nicotine Tob Res (2010) 1.76

National and state estimates of secondhand smoke infiltration among U.S. multiunit housing residents. Nicotine Tob Res (2012) 1.39

Attitudes, experiences, and acceptance of smoke-free policies among US multiunit housing residents. Am J Public Health (2012) 1.34

Prevalence and predictors of smoke-free policy implementation and support among owners and managers of multiunit housing. Nicotine Tob Res (2009) 1.26

Cost savings associated with prohibiting smoking in U.S. subsidized housing. Am J Prev Med (2013) 1.16

Estimates of smoking-related property costs in California multiunit housing. Am J Public Health (2011) 1.16

Intervention to promote smoke-free policies among multiunit housing operators. J Public Health Manag Pract (2011) 1.15

Smoke-free multiunit housing: a review of the scientific literature. Tob Control (2015) 1.09

Tobacco smoke incursions in multiunit housing. Am J Public Health (2014) 1.03

Individual, social, and environmental factors associated with support for smoke-free housing policies among subsidized multiunit housing tenants. Nicotine Tob Res (2012) 1.02

Comparison of indoor air quality in smoke-permitted and smoke-free multiunit housing: findings from the Boston Housing Authority. Nicotine Tob Res (2014) 0.99

Moving multiunit housing providers toward adoption of smoke-free policies. Prev Chronic Dis (2010) 0.96

Support for smoke-free multi-unit housing policies among racially and ethnically diverse, low-income seniors in South Florida. J Cross Cult Gerontol (2014) 0.90

Secondhand smoke exposure among Hispanics/Latinos living in multiunit housing: exploring barriers to new policies. Am J Health Promot (2011) 0.88

Predictors of smoke-free policies in affordable multiunit housing, North Carolina, 2013. Prev Chronic Dis (2015) 0.79

Exposure to secondhand smoke from neighbours and respiratory symptoms in never-smoking adolescents in Hong Kong: a cross-sectional study. BMJ Open (2015) 0.79

Smoke-Free Policies in Multiunit Housing: Smoking Behavior and Reactions to Messaging Strategies in Support or in Opposition. Prev Chronic Dis (2015) 0.78

Correlates of smoke-free housing policies and interest in implementing policies among multiunit housing owners in New York City. J Urban Health (2015) 0.75

Health, Secondhand Smoke Exposure, and Smoking Behavior Impacts of No-Smoking Policies in Public Housing, Colorado, 2014-2015. Prev Chronic Dis (2016) 0.75

Articles by these authors

(truncated to the top 100)

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet (2011) 5.76

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care (2013) 3.89

Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions. Cell Host Microbe (2011) 2.20

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. Lancet Oncol (2012) 2.06

Effects of dexmedetomidine on propofol and remifentanil infusion rates during total intravenous anesthesia for spine surgery in adolescents. Paediatr Anaesth (2008) 1.74

Diabetes and driving. Diabetes Care (2012) 1.66

Late fatigue fracture of a modern cemented [corrected] cobalt chrome stem for total hip arthroplasty: a report of 10 cases. J Arthroplasty (2005) 1.64

Open access in primary care: results of a North Carolina pilot project. Pediatrics (2005) 1.62

Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther (2006) 1.61

Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood (2004) 1.58

Recombinant human platelet-derived growth factor-BB and beta-tricalcium phosphate (rhPDGF-BB/β-TCP): an alternative to autogenous bone graft. J Bone Joint Surg Am (2013) 1.54

A molecular map of mesenchymal tumors. Genome Biol (2005) 1.52

A novel markerless technique to evaluate daily lung tumor motion based on conventional cone-beam CT projection data. Int J Radiat Oncol Biol Phys (2012) 1.48

Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial. Trials (2012) 1.48

Trauma during pregnancy: an analysis of maternal and fetal outcomes in a large population. Am J Obstet Gynecol (2004) 1.45

Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol (2005) 1.39

Human γδ T lymphocytes are licensed for professional antigen presentation by interaction with opsonized target cells. J Immunol (2012) 1.28

Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma. J Neurooncol (2010) 1.26

Relationship between MYCN copy number and expression in rhabdomyosarcomas and correlation with adverse prognosis in the alveolar subtype. J Clin Oncol (2005) 1.25

Prevalence, distribution, and host range of Peste des petits ruminants virus, Turkey. Emerg Infect Dis (2002) 1.21

Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial. BJU Int (2008) 1.19

Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas. J Natl Cancer Inst (2009) 1.19

Distributional impact of rotavirus vaccination in 25 GAVI countries: estimating disparities in benefits and cost-effectiveness. Vaccine (2012) 1.11

Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. J Clin Endocrinol Metab (2013) 1.08

An integrated theory of prospective time interval estimation: the role of cognition, attention, and learning. Psychol Rev (2007) 1.08

Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance. Vaccine (2005) 1.07

Polyphenon [corrected] E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells. Clin Cancer Res (2013) 1.06

Coordinated oncogenic transformation and inhibition of host immune responses by the PAX3-FKHR fusion oncoprotein. J Exp Med (2005) 1.06

Design, delivery, and validation of a trainer curriculum for the national laparoscopic colorectal training program in England. Ann Surg (2015) 1.06

Androgen-deprivation therapy-it's all a matter of timing. Eur Urol (2008) 1.05

Clinical and pathological features of paediatric malignant rhabdoid tumours. Pediatr Blood Cancer (2010) 1.04

Seven to 10 years followup of an anatomic hip prosthesis: an international study. Clin Orthop Relat Res (2004) 1.03

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK. Clin Cancer Res (2013) 1.02

Development and validation of a novel method for assessing competency in polypectomy: direct observation of polypectomy skills. Gastrointest Endosc (2011) 0.98

Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis (2004) 0.96

Training the endoscopy trainer: from general principles to specific concepts. Can J Gastroenterol (2010) 0.96

Patterns of shift in ADC distributions in abdominal tumours during chemotherapy-feasibility study. Pediatr Radiol (2010) 0.96

Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer disease. J Biol Chem (2009) 0.94

Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach. Crit Rev Oncol Hematol (2008) 0.93

Psychometric properties of the Revised Illness Perception Questionnaire: factor structure and reliability among African-origin populations with type 2 diabetes. Int J Nurs Stud (2011) 0.91

Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2'-Deoxycytidine. Cancer Immunol Immunother (2011) 0.90

Diabetes and driving. Diabetes Care (2014) 0.90

Evaluation of three 3ABC ELISAs for foot-and-mouth disease non-structural antibodies using latent class analysis. BMC Vet Res (2006) 0.90

Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. J Antimicrob Chemother (2011) 0.90

Physician and patient based outcomes following surgical resection of Haglund's deformity. Acta Orthop Belg (2005) 0.89

Ethnic differences and socio-demographic predictors of illness perceptions, self-management, and metabolic control of type 2 diabetes. Int J Gen Med (2013) 0.89

Characterisation and validation of insertions and deletions in 173 patient exomes. PLoS One (2012) 0.89

Tracking UNC-45 chaperone-myosin interaction with a titin mechanical reporter. Biophys J (2012) 0.88

The Brn-3b transcription factor regulates the growth, behavior, and invasiveness of human neuroblastoma cells in vitro and in vivo. J Biol Chem (2004) 0.87

Optimization of transthoracic ventricular defibrillation-biphasic and triphasic shocks, waveform rounding, and synchronized shock delivery. J Electrocardiol (2002) 0.87

Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration. BJU Int (2006) 0.87

Validation of the National Aeronautics and Space Administration Task Load Index as a tool to evaluate the learning curve for endoscopy training. Can J Gastroenterol Hepatol (2014) 0.86

Early use of magnetic endoscopic imaging by novice colonoscopists: improved performance without increase in workload. Can J Gastroenterol (2010) 0.86

The MET receptor tyrosine kinase contributes to invasive tumour growth in rhabdomyosarcomas. Growth Factors (2006) 0.85

Symptomatic thromboembolism after one-stage bilateral THA with a multimodal prophylaxis protocol. Clin Orthop Relat Res (2007) 0.85

The immune environment of paediatric solid malignancies: evidence from an immunohistochemical study of clinical cases. Fetal Pediatr Pathol (2013) 0.85

Rinderpest eradicated; what next? Vet Rec (2011) 0.85

Bone marrow-derived IFN-producing killer dendritic cells account for the tumoricidal activity of unpulsed dendritic cells. J Immunol (2008) 0.84

Improved tolerance to salt and water stress in Drosophila melanogaster cells conferred by late embryogenesis abundant protein. J Insect Physiol (2013) 0.84

Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case. Cancer Genet Cytogenet (2003) 0.83

Providers' constructions of pregnant and early parenting women who use substances. Sociol Health Illn (2014) 0.83

Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine. J Gen Virol (2007) 0.83

Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature. Pathol Oncol Res (2008) 0.83

MYCN as a target for cancer immunotherapy. Cancer Immunol Immunother (2007) 0.82

B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: implications for cell survival. Blood Cells Mol Dis (2007) 0.82

Development of anti-PAX3 immune responses; a target for cancer immunotherapy. Cancer Immunol Immunother (2007) 0.82

Persistent complete response after single-agent sunitinib treatment in a case of TFE translocation positive relapsed metastatic pediatric renal cell carcinoma. J Pediatr Hematol Oncol (2013) 0.82

Surgical management of chylopericardium and chylothorax in a patient with Behçet's disease. Clin Exp Rheumatol (2011) 0.81

Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors. Int J Colorectal Dis (2011) 0.81

PAX5 expression in nonhematopoietic tissues. Reappraisal of previous studies. Am J Clin Pathol (2010) 0.81

Improvement and development of rapid chromatographic strip-tests for the diagnosis of rinderpest and peste des petits ruminants viruses. J Virol Methods (2011) 0.81

Late fiber metal shedding of the first and second-generation Harris Galante acetabular component. A report of 5 cases. J Arthroplasty (2007) 0.81

Clinical and pathologic evidence of corticobasal degeneration and progressive supranuclear palsy in familial tauopathy. Arch Neurol (2005) 0.81

Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population. Aust N Z J Obstet Gynaecol (2004) 0.81

A novel small-molecule inhibitor of IL-6 signalling. Bioorg Med Chem Lett (2010) 0.81

STAT3 Regulates Proliferation and Immunogenicity of the Ewing Family of Tumors In Vitro. Sarcoma (2012) 0.80

The loss rates for invasive prenatal testing in a specialised obstetric ultrasound practice. Aust N Z J Obstet Gynaecol (2002) 0.80

Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry. Eur J Cancer (2010) 0.80

Pulsed electric field as a potential new method for microbial inactivation in scaffold materials for tissue engineering: the effect on collagen as a scaffold. J Biomed Mater Res A (2009) 0.79

Migratory and antigen presentation functions of IFN-producing killer dendritic cells. Cancer Res (2009) 0.79

Ultrasound-guided core needle biopsy for the diagnosis of rhabdomyosarcoma in childhood. Pediatr Blood Cancer (2009) 0.79

Epidemiologic study to explore links between Ménière syndrome and migraine headache. Ear Nose Throat J (2009) 0.78

Retracted Directed differentiation of mouse cochlear neural progenitors in vitro. Am J Physiol Cell Physiol (2008) 0.78

Autologous platelet gel: an in vitro analysis of platelet-rich plasma using multiple cycles. J Extra Corpor Technol (2006) 0.78

Congenital malignant rhabdoid tumor of the scalp. J Craniomaxillofac Surg (2011) 0.78

The inverse problem utilizing the boundary element method for a nonstandard female torso. IEEE Trans Biomed Eng (2010) 0.78

MYCN deregulation as a potential target for novel therapies in rhabdomyosarcoma. Expert Rev Anticancer Ther (2006) 0.78

Novel passive implantable atrial defibrillator using transcutaneous radiofrequency energy transmission successfully cardioverts atrial fibrillation. Circulation (2003) 0.78

Effect of pregnancy and obesity on arch of foot. Orthop Surg (2012) 0.78

The future of gastroenterology training: instruction in technical skills. Frontline Gastroenterol (2012) 0.78

Development of cellular immune responses against PAX5, a novel target for cancer immunotherapy. Cancer Res (2008) 0.77

Highly selective c-Jun N-terminal kinase (JNK) 3 inhibitors with in vitro CNS-like pharmacokinetic properties II. Central core replacement. Bioorg Med Chem Lett (2011) 0.77

Cells with dendritic cell morphology and immunophenotype, binuclear morphology, and immunosuppressive function in dendritic cell cultures. Cell Immunol (2011) 0.77

Usefulness of body surface maps to demonstrate ventricular activation patterns during left ventricular pacing and reentrant activation during ventricular tachycardia in men with coronary heart disease and left ventricular dysfunction. Am J Cardiol (2006) 0.77

Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors. J Pediatr Surg (2011) 0.76

Diabetes and driving. Diabetes Care (2013) 0.76

Treatment of prostate cancer with hormonal therapy in Europe. BJU Int (2009) 0.76

Uneventful administration of vincristine in Charcot-Marie-Tooth disease type 1X. Pediatr Blood Cancer (2008) 0.75

Using social-cognitive constructs to predict preoperative exercise before total joint replacement. Rehabil Psychol (2013) 0.75

Focusing on patients improves their functioning. J Psychosoc Nurs Ment Health Serv (2007) 0.75